Status: affected by wild poliovirus type 1 and circulating vaccine-derived poliovirus type 2

Afghanistan is affected by ongoing endemic wild poliovirus transmission. The Global Polio Eradication Initiative is focusing on reaching every last child in Afghanistan with vaccines, strengthening surveillance and maintaining political commitment, financial resources and technical support at all levels.

Polio this week in Afghanistan

  • Two wild poliovirus type 1 (WPV1) cases were reported in Hilmand province. There have been 56 WPV1 cases reported in 2020 so far while the total number of cases reported in 2019 remains 29.
  • 24 cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported; one each in Zabul, Uruzgan, Takhar, Paktika, Kunduz and Farah, five in Khost, nine in Kandahar and four in Hilmand. There are 160 cVDPV2 cases reported in 2020 so far.
  • 18 cVDPV2 positive environmental samples were reported; three in Nangahar, one each in Laghman, Khost, Kabul and Hirat, six in Kandahar and five in Hilmand
  • Read the latest polio snapshot from Afghanistan to see information on cases, surveillance and vaccination campaigns.

International Health Regulations

Afghanistan is classified by the International Health Regulations (IHR) as a state infected with WPV1 and cVDPV2 with potential risk of international spread. It is therefore subject to temporary recommendations as of October 2020.

 Travel advice

WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.

Related Resources